CORDIS is the Community Research and Development Information Service. It is the European Commission’s primary public repository and portal to disseminate information on all EU-funded research projects and their results in the broadest sense.
The Latest Bing News on:
CORDIS Research
- Cordis Announces Start Of Enrollment In RADIANCY Clinical Study In Europe'
Mirroring this innovation with research and a strong educational program to advance the field is truly at Cordis' core.' For healthcare professionals only. CAUTION: Federal (USA) law restricts ...
- Cordis Announces Start of Enrollment in RADIANCY Clinical Study in Europe
Mirroring this innovation with research and a strong educational program to advance the field is truly at Cordis' core." For healthcare professionals only. CAUTION: Federal (USA) law restricts this ...
- Cordis Announces Start of Enrollment in RADIANCY Clinical Study in Europe
Mirroring this innovation with research and a strong educational program to advance the field is truly at Cordis' core." For healthcare professionals only. CAUTION: Federal (USA) law restricts ...
The Latest Google Headlines on:
CORDIS Research
The Latest Bing News on:
CORDIS Discovery
- Man of Many’s Staff Favourites – 30 July 2022
Although Cordis Auckland is the city’s largest hotel, it doesn’t feel like it. Somehow it maintains the contemporary style, charm and personal service you’d expect from a smaller boutique ...
- Two Clinical Studies to Treat Mild-to-Moderate COVID-19 at Home Reveal Value of Exscalate, Dompé's AI Platform for Drug Design
New digital open tools for researches are now being developed with the support of the European High Performance Computing Joint Undertaking to further accelerate the drug discovery process.
- Two Clinical Studies to Treat Mild-to-Moderate COVID-19 at Home Reveal Value of Exscalate, Dompé’s AI Platform for Drug Design
Raloxifene was identified as a potential COVID-19 treatment by Exscalate4CoV consortium, a multidisciplinary European center of excellence created with the aim to fighting coronavirus by combining the ...
- STALICLA Awarded EUR 1.7 Million to Lead Computational Drug Repositioning Activities in EU-funded REPO4EU Project
This achievement is a strong acknowledgement of STALICLA’s technology and expertise in accelerating precision medicine discovery for patients with complex diseases.” It takes on average 15 ...
- STALICLA Awarded EUR 1.7 Million to Lead Computational Drug Repositioning Activities in EU-funded REPO4EU Project
STALICLA will be a leading contributor to the Euro-Global Platform for Mechanism-based Drug Repurposing (REPO4EU) consortium, with a EUR 1.7 million budget allocated to STALICLA Discovery and Data ...